No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S N/A · No P/S — trailing revenue unavailable or non-positive.
Chart series for revenue are being prepared.
The latest delayed quote for Freenome, Inc. (FRNM) stock was $16.83 as of Oct 5, 2026, 4:00 PM EDT, up 3.12% from the previous close.
Freenome is an early cancer detection company developing blood-based screening tests to identify cancer in its earliest, most treatable stages. The company's proprietary multiomics discovery platform analyzes circulating cell-free DNA methylation patterns at single-base resolution alongside additional biomarkers to detect multiple cancers.
Medical - Diagnostics & Research · Brisbane, CA
LATEST PRICE
$16.83
52-WEEK RANGE
$9.95 - $17.50
BETA
0.35
% FROM 52W HIGH
-3.83%
MARKET CAP
$137.29M
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
N/A
PE RATIO (FWD)
forward FY estimate
N/A
P/B RATIO
N/A
P/S RATIO
TTM
N/A
P/OCF RATIO
TTM
N/A
EV/EBITDA
TTM
N/A
DEBT / EQUITY
N/A
REVENUE TTM
N/A
GROSS MARGIN TTM
N/A
NET PROFIT MARGIN TTM
N/A
REVENUE GROWTH TTM
TTM vs prior TTM
N/A
REVENUE CAGR 3Y
N/A
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
N/A
3Y TOTAL RETURN
annualized (CAGR)
N/A
5Y TOTAL RETURN
annualized (CAGR)
N/A
Next Earnings Date
Dec 2, 2026
57 days away
EPS Estimate
0.14
Revenue Est.
$84.94M
Last Quarter Results
EPS
$-1.91
vs Estimate
$-1.77
Revenue
$3.20M
vs Estimate
$3.02M
Consensus Rating
Based on 5 analysts
Average Price Target
$18.00
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1FRNM | $137.29M | $16.83 | +3.12% | N/A | N/A | N/A | N/A |
| 2KRMD | $138.26M | $3.01 | +1.69% | -21.73% | +1.60% | +21.21% | vs FRNM |
| 3AIRS | $134.74M | $1.91 | +7.91% | -75.16% | N/A | N/A | vs FRNM |
| 4ACOG | $142.11M | $9.15 | +0.55% | +22.21% | N/A | N/A | vs FRNM |
| 5FBIOP | $142.49M | $18.10 | +7.35% | +144.21% | +0.05% | N/A | vs FRNM |
| 6KRSA | $143.81M | $30.72 | +0.75% | +75.07% | -40.41% | N/A | vs FRNM |
+7.0% upside
Low
$17.00
Current
$16.83
High
$21.00